Quarterly report pursuant to Section 13 or 15(d)

Description of Business and Summary of Significant Accounting Policies (Details Textual)

v3.5.0.2
Description of Business and Summary of Significant Accounting Policies (Details Textual) - USD ($)
1 Months Ended 6 Months Ended
Aug. 31, 2015
Jun. 30, 2016
Dec. 31, 2015
Description Of Business And Summary Of Significant Accounting Policies [Line Items]      
Retained Earnings (Accumulated Deficit), Total   $ (1,819,328) $ (748,360)
Cash, Uninsured Amount   $ 6,744,684  
Warrant [Member]      
Description Of Business And Summary Of Significant Accounting Policies [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   107,802  
Employee Stock Option [Member]      
Description Of Business And Summary Of Significant Accounting Policies [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   200,000  
Convertible Debt Securities [Member]      
Description Of Business And Summary Of Significant Accounting Policies [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   2,691,803  
Use Rights [Member] | AnnaMed, Inc [Member]      
Description Of Business And Summary Of Significant Accounting Policies [Line Items]      
Stock Issued During Period, Shares, Purchase of Assets 1,431,000    
Use Rights [Member] | IntertechBio Corporation [Member]      
Description Of Business And Summary Of Significant Accounting Policies [Line Items]      
Stock Issued During Period, Shares, Purchase of Assets 630,000